Saturday 17 October 2026
Export HNGE’s income statement to Excel — free account
Hinge Health Inc.
HNGE Healthcare Health Information Services
Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024. In the quarter to June 2026, revenue grew 53.0%, EPS grew 104.2% and free cash flow grew 441.1%, each against the same quarter a year earlier.
99.16
5.80
−5.53%
Follow HNGE
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | — | 33.42 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | — | 62.18 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | 1,514 | 1,437 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | — | 0.00 | 0.26 | 0.41 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 293 | 390 | 588 | ||||
| Gross margin, % | — | — | — | — | — | — | — | 66.33 | 76.82 | 79.65 | |||||
| EBT | — | — | — | — | — | — | — | (109) | (11) | (527) | |||||
| EBT margin, % | — | — | — | — | — | — | — | (37.08) | (2.88) | (89.69) | |||||
| Net income | — | — | — | — | — | — | — | (108) | (12) | (528) | |||||
| Depreciation | — | — | — | — | — | — | — | 15 | 36 | 52 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | 22.49 | 28.80 | 10.77 | ||||
| Earnings | — | — | — | — | — | — | — | (8.31) | (0.88) | (7.77) | |||||
| Cash flow | — | — | — | — | — | — | — | (4.91) | 3.61 | 3.14 | |||||
| Capex | — | — | — | — | — | — | — | (0.35) | (0.28) | (0.11) | |||||
| Free cash flow | — | — | — | — | — | — | — | (5.26) | 3.34 | 3.03 | |||||
| Book value | — | — | — | — | — | — | — | (32.57) | (32.05) | 3.27 | |||||
| Shares, m | — | — | — | — | — | — | — | 13 | 14 | 55 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | — | — | 0.00 | 0.00 | 4.31 | |||||
| P/B | — | — | — | — | — | — | — | 0.00 | 0.00 | 14.19 | |||||
| EV/Sales | — | — | — | — | — | — | — | 0.00 | 0.00 | 3.69 | |||||
| EV/FCF | — | — | — | — | — | — | — | 2.07 | 2.07 | 13.13 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | (64) | 49 | 171 | ||||
| Capex | — | — | — | — | — | — | — | (5) | (4) | (6) | |||||
| Free cash flow | — | — | — | — | — | — | — | (69) | 45 | 165 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | 346 | 334 | 171 | ||||
| Total debt | — | — | — | — | — | — | — | — | — | — | |||||
| Net debt | — | — | — | — | — | — | — | (423) | (467) | (364) | |||||
| Shareholders’ equity | — | — | — | — | — | — | — | (424) | (435) | 179 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | 0.00 | (1.84) | (59.81) | ||||
| ROIC | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | |||||
| ROE | — | — | — | — | — | — | — | 0.00 | 2.78 | 331.44 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Hinge Health Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| TEM Tempus AI, Inc. | $12.8B | — (loss-making) | — (loss-making) | +21.56% (above 0%: growing) | n/m | −153.72% (below 0%: shrinking) | 64.45% | (19.85%) | Compare |
| BTSG BrightSpring Health Services, Inc. | $12.3B | 34.0× | 37.6× | +23.05% (above 0%: growing) | +192.86% (above 0%: growing) | −39.62% (below 0%: shrinking) | 12.72% | 3.37% | Compare |
| TXG 10x Genomics | $9.4B | — (loss-making) | — (loss-making) | −12.65% (below 0%: shrinking) | n/m | −4.61% (below 0%: shrinking) | 74.48% | (12.95%) | Compare |
| HNGE Hinge Health Inc. | $8.5B | 73.5× | 39.4× | +53.00% (above 0%: growing) | n/m | +441.14% (above 0%: growing) | 86.44% | 19.00% | |
| HQY HealthEquity, Inc. | $7.7B | 33.0× | 30.2× | +7.64% (above 0%: growing) | +14.49% (above 0%: growing) | −3.44% (below 0%: shrinking) | 73.55% | 28.14% | Compare |
| DOCS Doximity, Inc. | $5.6B | 34.8× | 26.2× | +7.34% (above 0%: growing) | −53.57% (below 0%: shrinking) | −34.14% (below 0%: shrinking) | 84.87% | 21.48% | Compare |
| WAY Waystar Holding Corp. | $5.4B | 38.0× | 22.4× | +18.11% (above 0%: growing) | +10.53% (above 0%: growing) | −52.42% (below 0%: shrinking) | 69.44% | 23.79% | Compare |
| HTFL Heartflow, Inc. | $4.4B | — (loss-making) | — (loss-making) | +47.57% (above 0%: growing) | n/m | +62.62% (above 0%: growing) | 83.00% | (27.93%) | Compare |
| PRVA Privia Health Group, Inc. | $2.9B | 102× | 87.8× | +21.39% (above 0%: growing) | +250.00% (above 0%: growing) | −86.20% (below 0%: shrinking) | 9.93% | 1.86% | Compare |
| Median of peers | $6.6B | 34.8× | 30.2× | +19.75% | +14.49% | −36.88% | 71.50% | 2.62% |
Hinge Health Inc. (HNGE) key facts
- Strength: Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024.
- Hinge Health Inc. (HNGE) is a Health Information Services company in the Healthcare sector, listed on the New York Stock Exchange.
- As of October 16, 2026, HNGE traded at $99.16, a market capitalization of $8.5 billion.
- Return on equity was 331.4% and debt-to-equity 0.00.
- Its Piotroski F-score is 5 out of 9 and its Altman Z-score is −0.64 (distress zone) for fiscal 2025.